Safety of thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack.
Safety of thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack.
复制标题
近期短暂性脑缺血发作后急性缺血性卒中溶栓治疗的安全性。
DOI:
10.1016/j.jstrokecerebrovasdis.2010.12.008
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Cucchiara,BrettL
中科院分区:
文献类型:
--
作者:
McKinney,JamesS;Masjuan,Jaime;Purroy,Francisco;Calvet,David;Ay,Hakan;Cucchiara,BrettL
BACKGROUNDThe objective of this study was to assess the rate of symptomatic intracerebral hemorrhage (SICH) in patients given thrombolytic therapy for acute ischemic stroke (AIS) after recent transient ischemic attack (TIA).METHODSThis was a multicenter study of patients with confirmed TIA within 7 days before an AIS that was treated with intravenous (IV), intra-arterial (IA), or mechanical thrombolysis. A total of 23 cases were identified.RESULTSThe median time interval between index TIA and AIS was 9 hours. The median National Institutes of Health Stroke Scale score at the time of AIS was 12. The median time interval between stroke onset and thrombolytic treatment was 90 minutes. Thrombolytic therapies included IV thrombolysis (70%), IA thrombolysis (17%), IA and mechanical thrombolysis (9%), and IV followed by IA and mechanical thrombolysis (4%). The rate of postthrombolysis SICH in this group was 8.6% (2/23).CONCLUSIONSThe rate of SICH in our cohort appears similar to overall postthrombolysis hemorrhage rates.